公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2015 | Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010 | Kuo H.-C.; HO-HSIUNG LIN ; HONG-JENG YU ; Cheng C.-L.; Hung M.-J.; Lin A.T.L.; Chang C.-H.; Chuang Y.-C.; Cha T.-L.; Chen G.-D.; Chen C.-S.; Wu M.-P.; Wu T.-L.; Yu K.-J.; Huang S.-T.; The Taiwan Mirabegron Study Team | Urological Science | 0 | 0 | |
2018 | O-Glycosylation¡Vmediated signaling circuit drives metastatic castration-resistant prostate cancer | Tzeng S.-F.; Tsai C.-H.; Chao T.-K.; Chou Y.-C.; Yang Y.-C.; MONG-HSUN TSAI ; Cha T.-L.; Hsiao P.-W. | FASEB Journal | |||
2017 | Optimal usage of radium-223 in metastatic castration-resistant prostate cancer | Cha T.-L.; Wu T.T.-L.; Vogelzang N.J.; CHAO-YUAN HUANG ; Huang S.-P.; CHIA-CHI LIN ; Ou Y.-C.; Pang S.-T.; Shen D.H.-Y.; Wu W.-J.; Chang W.Y.-H. | Journal of the Formosan Medical Association | 15 | 14 |